DNAポリメラーゼβの選択的阻害
Shelby C Yuhas1, Daniel J Laverty1, Huijin Lee1
1Johns Hopkins University, Department of Chemistry, 3400 North Charles Street, Baltimore, Maryland 21218, United States.
Journal of the American Chemical Society
|May 20, 2021
まとめ
研究者はDNA修復と癌における重要な酵素であるDNAポリメラーゼβ (Pol β) を選択的に標的とする新しい共性阻害剤を開発した. このPol β阻害剤は,疾患とがん治療におけるその役割の研究のツールとして有望である.
科学分野:
- 生物化学
- 分子生物学
- 薬剤化学
背景:
- DNAポリメラーゼβ (Pol β) はDNA修復に不可欠であり,がん発症に関与しています.
- 現在,Pol βの選択的阻害剤は不足しており,研究と治療開発を妨げています.
- DNAの損傷を引き起こす抗腫瘍剤は,Pol βを無効化し,阻害剤の設計のための基礎を提供します.
研究 の 目的:
- DNAポリメラーゼβ (Polβ) を標的とする新しい共性小分子阻害剤を開発する.
- 特定されたPol β阻害剤の選択性と作用機構を特徴づける.
- 癌研究のための細胞モデルにおけるプロ阻害剤 (pro-14) の可能性を評価する.
主な方法:
- 化学合成されたライブラリは,2段階のスクリーニングプロセスで阻害剤を特定するために使用されました.
- 酵素阻害試験 (KI,kinact) と他のDNAポリメラーゼに対する選択性プロファイリングが行われました.
- 液体染色体-タンデム質量スペクトロメトリー (LC-MS/MS) を用いて,Pol βの共性変異部位を特定した.
- 光アニソトロピーは,Pol β DNA結合に対する抑制剤の効果を評価するために用いられました.
- 野生型およびPol β-nullマウス胚性線維芽細胞 (MEF) とHeLa細胞における細胞ベースの測定は,pro-14とDNAダメージを与える物質を組み合わせて実施した.
主要な成果:
- Pol βの強力な不可逆的阻害剤 (14) は,KI = 1.8 ± 0. 45 μMとkinact = (7. 0 ± 1. 0) × 10-3 s-1と特定されました.
- 抑制剤14は選択性を示し,他のDNAポリメラーゼに対してPolβを無効化する.
- LC-MS/MS分析では,Pol β結合部位内の2つのライシンが,阻害剤14によって共性的に変化していることが明らかになった.
- 抑制剤14による前治療は,Pol βのDNA結合能力を阻害した.
- プロ阻害剤 (pro-14) は単独では細胞毒性ではなく,メチルメタネスルフォナート (MMS) とブレオミシンと連携して癌細胞を殺害しました.
- 細胞実験により,プロ14のPolβの選択性が確認された.
結論:
- 新しい共性阻害剤 (14) とそのプロ阻害剤 (pro-14) は選択的にDNAポリメラーゼβ (Polβ) を標的とする.
- これらの阻害剤は,Pol β活性部位の鍵となるライシン残基を共性的に改変し,DNA結合を防ぐ.
- Pro-14は,がん細胞系におけるDNAダメージを与える物質と,共効性のある細胞毒性を示しています.
- 開発された阻害剤は,DNA修復と疾患におけるPol βの機能を調査するための貴重なツールであり,潜在的な治療効果がある.
関連する概念動画
Restarting Stalled Replication Forks
6.0K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.0K
Eukaryotic Transcription Inhibitors
10.2K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.2K
Translesion DNA Polymerases
10.4K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.4K
DNA Topoisomerases
33.3K
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
33.3K
Enzyme Inhibition
87.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
87.5K
Proofreading
7.4K
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase...
Errors During Replication are Corrected by the DNA Polymerase...
7.4K


